FMI
DNTH icon

F/M Investments’s Dianthus Therapeutics DNTH Stock Holding History

F/M Investments’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
+35,875
New +$3.13M 0.18% 93

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

F/M Investments's DNTH Position: Q2 2026 in Review

F/M Investments opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 35,875 shares worth $3.5M. The stake represents 0.18% of the portfolio and ranks #93 among its holdings.

268 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • F/M Investments held 35,875 shares of Dianthus Therapeutics worth $3.5M as of Q2 2026.
  • Dianthus Therapeutics was a new F/M Investments position in Q2 2026.
  • Dianthus Therapeutics made up 0.18% of F/M Investments's portfolio in Q2 2026, its #93 holding.
  • 268 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.